Publications by authors named "A L Suss"
This study explored cognitive effects on narrative macrostructure in both languages of 38 Russian-German bilinguals aged 4;6 to 5;1' while controlling for demographic factors (sex, socioeconomic status) and language proficiency. Macrostructure was operationalised as story structure (SS) and story complexity (SC) using the Multilingual Assessment Instrument for Narratives. Nonverbal cognitive subtasks assessing shifting (Figure Ground), visual memory (Form Completion), and inhibition (Attention Divided) were administered.
View Article and Find Full Text PDFArticle Synopsis
- The study explored if neuronal complexity could be used as a reliable indicator of neural epileptic activity (EA) in patients, distinguishing them from those with non-epileptic events.
- Reducing anti-seizure medication during video-EEG monitoring led to a significant decrease in neuronal complexity in patients with epilepsy, while control patients showed no such change.
- Neuronal complexity effectively differentiated epilepsy patients from non-epileptic patients, with a notable area under the curve (AUC) of 0.76, proving more useful than delta power in this context.
Juvenile hormone is considered to be a master regulator of polyphenism in social insects. In the ant Cardiocondyla obscurior, whether a female egg develops into a queen or a worker is determined maternally and caste-specific differentiation occurs in embryos, so that queens and workers can be distinguished in a non-invasive manner from late embryogenesis onwards. This ant also exhibits two male morphs - winged and wingless males.
View Article and Find Full Text PDFBackground: G-EPOSS is a prospective, non-interventional, German multicentre study of patients with moderate-to-severe plaque psoriasis receiving guselkumab, a therapeutic monoclonal antibody targeting interleukin-23, in a real-world setting.
Objectives: The objective of the study was to evaluate the effectiveness and safety of guselkumab, including its impact on skin, health-related quality of life (HRQoL), sexuality, and perceived stigmatization.
Methods: Patients (≥18 years old) received guselkumab per routine clinical practice.